» Articles » PMID: 12948495

A 1.7A Structure of Fve, a Member of the New Fungal Immunomodulatory Protein Family

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2003 Sep 2
PMID 12948495
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Fve, a major fruiting body protein from Flammulina velutipes, a mushroom possessing immunomodulatory activity, stimulates lymphocyte mitogenesis, suppresses systemic anaphylaxis reactions and edema, enhances transcription of IL-2, IFN-gamma and TNF-alpha, and hemagglutinates red blood cells. It appears to be a lectin with specificity for complex cell-surface carbohydrates. Fve is a non-covalently linked homodimer containing no Cys, His or Met residues. It shares sequence similarity only to the other fungal immunomodulatory proteins (FIPs) LZ-8, Gts, Vvo and Vvl, all of unknown structure. The 1.7A structure of Fve solved by single anomalous diffraction of NaBr-soaked crystals is novel: each monomer consists of an N-terminal alpha-helix followed by a fibronectin III (FNIII) fold. The FNIII fold is the first instance of "pseudo-h-type" topology, a transition between the seven beta-stranded s-type and the eight beta-stranded h-type topologies. The structure suggests that dimerization, critical for the activity of FIPs, occurs by 3-D domain swapping of the N-terminal helices and is stabilized predominantly by hydrophobic interactions. The structure of Fve is the first in this lectin family to be reported, and the first of an FNIII domain-containing protein of fungal origin.

Citing Articles

Botulinum neurotoxins exploit host digestive proteases to boost their oral toxicity via activating OrfXs/P47.

Gao L, Nowakowska M, Selby K, Przykopanski A, Chen B, Kruger M Nat Struct Mol Biol. 2025; .

PMID: 39838108 DOI: 10.1038/s41594-024-01479-0.


Characterization, Recombinant Production, and Bioactivity of a Novel Immunomodulatory Protein from .

Yu S, Wang Y, Wu Y, Bao D, Bing W, Li Y Molecules. 2023; 28(12).

PMID: 37375351 PMC: 10304396. DOI: 10.3390/molecules28124796.


Safety assessment of the fungal immunomodulatory protein from (GMI) derived from engineered : Genetic toxicology, a 13-week oral gavage toxicity study, and an embryo-fetal developmental toxicity study in Sprague-Dawley rats.

Fu H, Hseu R Toxicol Rep. 2022; 9:1240-1254.

PMID: 36518484 PMC: 9742912. DOI: 10.1016/j.toxrep.2022.05.013.


FIP-nha, a fungal immunomodulatory protein from , induces apoptosis and autophagy in human gastric cancer cells via blocking the EGFR-mediated STAT3/Akt signaling pathway.

Li S, Hou L, Gao Y, Zhang N, Fan B, Wang F Food Chem (Oxf). 2022; 4:100091.

PMID: 35415679 PMC: 8991989. DOI: 10.1016/j.fochms.2022.100091.


Ganoderma immunomodulatory proteins: mushrooming functional FIPs.

Lin J, Chen H, Bai Y, Li S, Liang G, Fan T Appl Microbiol Biotechnol. 2022; 106(7):2367-2380.

PMID: 35348851 DOI: 10.1007/s00253-022-11839-9.